Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease

D Goldblatt, G Alter, S Crotty… - Immunological reviews, 2022 - Wiley Online Library
Antibodies against epitopes in S1 give the most accurate CoP against infection by the SARS‐
CoV‐2 coronavirus. Measurement of those antibodies by neutralization or binding assays …

Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice

NYL Pang, ASR Pang, VT Chow, DY Wang - Military Medical Research, 2021 - Springer
SARS-CoV-2 is a newly identified member of the coronavirus family that has caused the
Coronavirus disease 2019 (COVID-19) pandemic. This rapidly evolving and unrelenting …

Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic

LF Buss, CA Prete Jr, CMM Abrahim, A Mendrone Jr… - Science, 2021 - science.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly in Manaus,
the capital of Amazonas state in northern Brazil. The attack rate there is an estimate of the …

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD

NA Kennedy, S Lin, JR Goodhand, N Chanchlani… - Gut, 2021 - gut.bmj.com
Objective Delayed second dose SARS-CoV-2 vaccination trades maximal effectiveness for a
lower level of immunity across more of the population. We investigated whether patients with …

Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection

A Israel, Y Shenhar, I Green, E Merzon, A Golan-Cohen… - Vaccines, 2021 - mdpi.com
Immune protection following either vaccination or infection with SARS-CoV-2 is thought to
decrease over time. We designed a retrospective study, conducted at Leumit Health …

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

M Cornberg, M Buti, CS Eberhardt, PA Grossi… - Journal of …, 2021 - Elsevier
According to a recent World Health Organization estimate, the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pandemic, which originated in China in 2019, has …

Anti-spike protein assays to determine SARS-CoV-2 antibody levels: a head-to-head comparison of five quantitative assays

T Perkmann, N Perkmann-Nagele, T Koller… - Microbiology …, 2021 - Am Soc Microbiol
Reliable quantification of the antibody response to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is highly relevant, eg, for identifying possible vaccine failure …

Antibody titres decline 3-month post-vaccination with BNT162b2

J Favresse, JL Bayart, F Mullier, M Elsen… - Emerging microbes & …, 2021 - Taylor & Francis
Several studies reported on the humoral response in subjects having received the
BNT162b2 mRNA COVID-19 vaccine. However, data on the kinetics of antibodies 3 months …

Waning of IgG, total and neutralizing antibodies 6 months post-vaccination with BNT162b2 in healthcare workers

JL Bayart, J Douxfils, C Gillot, C David, F Mullier… - Vaccines, 2021 - mdpi.com
Data about the long-term duration of antibodies after SARS-CoV-2 vaccination are still
scarce and are important to design vaccination strategies. In this study, 231 healthcare …

[HTML][HTML] How to interpret and use COVID-19 serology and immunology tests

DSY Ong, PC Fragkou, VA Schweitzer… - Clinical Microbiology …, 2021 - Elsevier
Background Although molecular tests are considered the reference standard for coronavirus
disease 2019 (COVID-19) diagnostics, serological and immunological tests may be useful in …